Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...

Former CEO Anne Wojcicki has prevailed in the bankruptcy auction of 23andMe, its consumer and biopharma research businesses, ...

House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...

Its co-founder and CEO Anne Wojcicki also ... Officer George Yancopoulos said in a statement. Regeneron said Monday that it will comply with 23andMe's privacy policies and applicable law, process ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

The consumer privacy ombudsman tasked with analyzing the impact of 23andMe’s bankruptcy sale on individuals’ privacy has ...

Regeneron has agreed to buy 23andMe ... ensure our mission will carry forward," 23andMe interim CEO Joe Selsavage said in a statement. "With the support of Regeneron and their deep experience ...

Attorneys for co-founder and former CEO Anne Wojcicki plan an objection to 23andMe's sale to Regeneron. © 2025 American City Business Journals. All rights reserved ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.